Skip to main content
Toggle navigation
Login
Search
Home
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Back
Favorite
Facebook
Tweet
Print
Pierre Arvis, MD
Bayer Pharmaceuticals
Lille, Nord-Pas-de-Calais, France
Presentation(s):
Paper 24 - LONG-TERM EFFICACY AND SAFETY OF LAROTRECTINIB IN PEDIATRIC PATIENTS WITH TROPOMYOSIN RECEPTOR KINASE FUSION SARCOMAS
Thursday, November 17, 2022
2:08 PM – 2:16 PM
